Skip to main content
. 2017 Sep 28;3(2):e000523. doi: 10.1136/rmdopen-2017-000523

Table 2.

Incidence rate in the study sample according to drug exposure

Incident rheumatoid arthritis Person-years Exposure periods Incident rate *1000/yr (95% CI)
Tamoxifen 26 8650.2 3371 3.01 (1.96 to 4.40)
Aromatase inhibitors 87 17 455.7 6815 4.98 (3.99 to 6.15)
 Anastrozole 50 9457.8 3170 5.29 (3.92 to 6.97)
 Letrozole 30 6626.6 2785 4.53 (3.05 to 6.46)
 Exemestane 7 1371.3 860 5.10 (2.05 to 10.5)